Patents Assigned to Hope Medical Enterprises, Inc.
-
Publication number: 20250066195Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.Type: ApplicationFiled: November 14, 2024Publication date: February 27, 2025Applicant: Hope Medical Enterprises, Inc. dba Hope PharmaceuticalsInventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
-
Publication number: 20250042740Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.Type: ApplicationFiled: August 14, 2024Publication date: February 6, 2025Applicant: Hope Medical Enterprises, Inc. dba Hope PharmaceuticalsInventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
-
Patent number: 12186337Abstract: Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.Type: GrantFiled: January 18, 2023Date of Patent: January 7, 2025Assignee: Hope Medical Enterprises, Inc.Inventors: Craig Sherman, Anthony James Lepine, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
-
Publication number: 20240285677Abstract: Provided herein are methods for maintaining physiological levels of nitrite in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium nitrite to a subject undergoing hemodialysis.Type: ApplicationFiled: May 8, 2024Publication date: August 29, 2024Applicant: Hope Medical Enterprises, Inc. dba Hope PharmaceuticalsInventor: Craig Sherman
-
Publication number: 20240277758Abstract: Provided herein are formulations comprising sodium thiosulfate. Also provided herein are methods of treating, preventing or ameliorating a sulfur mustard skin injury in a subject, wherein the methods comprise contacting the subject with a formulation provided herein.Type: ApplicationFiled: December 27, 2023Publication date: August 22, 2024Applicant: Hope Medical Enterprises, Inc. dba Hope PharmaceuticalsInventors: Craig Sherman, Micah Bodner, Jon Marshall
-
Patent number: 12011456Abstract: Provided herein are methods for maintaining physiological levels of nitrite in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium nitrite to a subject undergoing hemodialysis.Type: GrantFiled: January 3, 2023Date of Patent: June 18, 2024Assignee: Hope Medical Enterprises, Inc.Inventor: Craig Sherman
-
Publication number: 20240100086Abstract: Provided herein are methods for maintaining physiological levels of thiosulfate in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium thiosulfate to a subject undergoing hemodialysis.Type: ApplicationFiled: August 29, 2023Publication date: March 28, 2024Applicant: Hope Medical Enterprises, Inc. dba Hope PharmaceuticalsInventor: Craig Sherman
-
Publication number: 20240101422Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.Type: ApplicationFiled: July 25, 2023Publication date: March 28, 2024Applicant: Hope Medical Enterprises, Inc. dba Hope PharmaceuticalsInventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
-
Patent number: 11779596Abstract: Provided herein are methods for maintaining physiological levels of thiosulfate in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium thiosulfate to a subject undergoing hemodialysis.Type: GrantFiled: August 9, 2021Date of Patent: October 10, 2023Assignee: HOPE MEDICAL ENTERPRISES, INC.Inventor: Craig Sherman
-
Patent number: 11753300Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.Type: GrantFiled: September 8, 2021Date of Patent: September 12, 2023Assignee: Hope Medical Enterprises, Inc.Inventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
-
Patent number: 11753301Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.Type: GrantFiled: February 13, 2023Date of Patent: September 12, 2023Assignee: Hope Medical Enterprises, Inc.Inventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
-
Publication number: 20230256005Abstract: Provided herein are methods for maintaining physiological levels of nitrite in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium nitrite to a subject undergoing hemodialysis.Type: ApplicationFiled: January 3, 2023Publication date: August 17, 2023Applicant: Hope Medical Enterprises, Inc. dba Hope PharmaceuticalsInventor: Craig Sherman
-
Publication number: 20230183067Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.Type: ApplicationFiled: February 13, 2023Publication date: June 15, 2023Applicant: Hope Medical Enterprises, Inc. dba Hope PharmaceuticalsInventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
-
Patent number: 11583550Abstract: Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.Type: GrantFiled: December 18, 2020Date of Patent: February 21, 2023Assignee: Hope Medical Enterprises, Inc.Inventors: Craig Sherman, Anthony James Lepine, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
-
Patent number: 11564938Abstract: Provided herein are methods for maintaining physiological levels of nitrite in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium nitrite to a subject undergoing hemodialysis.Type: GrantFiled: November 23, 2020Date of Patent: January 31, 2023Assignee: Hope Medical Enterprises, Inc.Inventor: Craig Sherman
-
Publication number: 20220063999Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.Type: ApplicationFiled: September 8, 2021Publication date: March 3, 2022Applicant: Hope Medical Enterprises, Inc. dba Hope PharmaceuticalsInventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
-
Publication number: 20220031735Abstract: Provided herein are methods for maintaining physiological levels of thiosulfate in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium thiosulfate to a subject undergoing hemodialysis.Type: ApplicationFiled: August 9, 2021Publication date: February 3, 2022Applicant: Hope Medical Enterprises, Inc. dba Hope PharmaceuticalsInventor: Craig Sherman
-
Patent number: 11142456Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.Type: GrantFiled: June 19, 2020Date of Patent: October 12, 2021Assignee: Hope Medical Enterprises, Inc.Inventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
-
Patent number: 11116790Abstract: Provided herein are methods for maintaining physiological levels of thiosulfate in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium thiosulfate to a subject undergoing hemodialysis.Type: GrantFiled: July 13, 2020Date of Patent: September 14, 2021Assignee: Hope Medical Enterprises, Inc.Inventor: Craig Sherman
-
Publication number: 20210077524Abstract: Provided herein are methods for maintaining physiological levels of nitrite in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium nitrite to a subject undergoing hemodialysis.Type: ApplicationFiled: November 23, 2020Publication date: March 18, 2021Applicant: Hope Medical Enterprises, Inc. dba Hope PharmaceuticalsInventor: Craig Sherman
